Injection Drug Users in the United States, 1979-2002
Open Access
- 22 January 2007
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 167 (2) , 166-173
- https://doi.org/10.1001/archinte.167.2.166
Abstract
Injection drug use (IDU) has an immediate and deleterious effect on individuals and communities and provides an efficient mechanism for transmitting blood-borne viruses, including human immunodeficiency virus, hepatitis C virus (HCV), and hepatitis B virus. All 3 can cause chronic asymptomatic infections that can eventually lead to severe illnesses years after the initial infection.1-3 Thus, former injection drug users remain at risk for the consequences of IDU long after they have quit using drugs.This publication has 10 references indexed in Scilit:
- Faculty Opinions recommendation of The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.Published by H1 Connect ,2007
- Hepatitis B, hepatitis C, and HIV in correctional populations: a review of epidemiology and preventionAIDS, 2005
- Drug Abuse Trends among Youth in the United StatesAnnals of the New York Academy of Sciences, 2004
- Changing Patterns in Causes of Death in a Cohort of Injecting Drug Users, 1980-2001Archives of internal medicine (1960), 2004
- Prevalence Of HIV, Syphilis, Hepatitis B, and Hepatitis C Among Entrants to Maryland Correctional FacilitiesJournal of Urban Health, 2004
- Natural history of chronic hepatitis CHepatology, 2002
- The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United StatesHepatology, 2000
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999
- A persistent rise in mortality among injection drug users in Rome, 1980 through 1992.American Journal of Public Health, 1997
- Hepatitis B virus.The major etiology of hepatocellular carcinomaCancer, 1988